Prostate Cancer - Results from #2320

ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. August 18, 2023

PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate. August 18, 2023

Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective. August 17, 2023

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer. August 17, 2023

An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading. August 17, 2023

The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy. August 17, 2023

Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET. August 17, 2023

Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer. August 16, 2023

Defining aggressive prostate cancer: a geospatial perspective. August 16, 2023

Evaluating the Learning Curve for In-Office Freehand Cognitive Fusion Transperineal Prostate Biopsy. August 16, 2023

Surgical and functional outcomes of Retzius-sparing robotic-assisted radical prostatectomy versus conventional robotic-assisted radical prostatectomy in patients with biopsy-confirmed prostate cancer. Are outcomes worth it? Systematic review and meta-anal August 16, 2023

Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study. August 16, 2023

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial. August 15, 2023

Management of patients with localized prostate cancer and biochemical recurrence in Spain: A medical survey. August 15, 2023

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis. August 15, 2023

U.S. FDA Approves AKEEGA™ (Niraparib and Abiraterone Acetate), the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer August 14, 2023

Standardized PSMA-PET Imaging of Advanced Prostate Cancer. August 14, 2023

Reliability and Efficiency of the CAPRI-3 Metastatic Prostate Cancer Registry Driven by Artificial Intelligence. August 14, 2023

Impact of [177Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [68Ga]Ga-PSMA-11-PET/CT. August 14, 2023

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. August 14, 2023

Page 117 of 1439